The cancer drugs market is projected to reach a staggering $594.3 billion by 2035, largely due to the rise of precision technologies and advanced immunotherapies that...
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) experienced a significant surge of 22.12% in after-hours trading on Tuesday, closing at $1.27. This increase follows the company’s fiscal year 2025...
